Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARY M DAVIS

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1982055869
CMS profile
10714583
Location
IRVING, TX

General Payments · PY2022–2024

$1,923.10

  • Reported across 64 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,014.92

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,014.92 36

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $167.18 5
PY2023 $741.00 23
PY2024 $1,014.92 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $18.84 03/21/2024 Food and Beverage Undisputed 01/23/2026 1104706485 CMS
AstraZeneca Pharmaceuticals LP $20.32 06/26/2024 Food and Beverage Undisputed 01/23/2026 1104421457 CMS
AstraZeneca Pharmaceuticals LP $20.19 11/14/2024 Food and Beverage Undisputed 01/23/2026 1105787754 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.68 04/03/2024 Food and Beverage Undisputed 01/23/2026 1118259379 CMS
CVRx, Inc. $6.59 03/27/2024 Food and Beverage Undisputed 01/23/2026 1128519728 CMS
CVRx, Inc. $104.99 05/20/2024 Food and Beverage Undisputed 01/23/2026 1128519730 CMS
CVRx, Inc. $17.18 06/21/2024 Food and Beverage Undisputed 01/23/2026 1128519732 CMS
CVRx, Inc. $4.74 10/31/2024 Food and Beverage Undisputed 01/23/2026 1128519734 CMS
CVRx, Inc. $161.51 11/20/2024 Food and Beverage Undisputed 01/23/2026 1128519736 CMS
E.R. Squibb & Sons, L.L.C. $15.99 03/25/2024 Food and Beverage Undisputed 01/23/2026 1101213308 CMS
E.R. Squibb & Sons, L.L.C. $18.81 04/18/2024 Food and Beverage Undisputed 01/23/2026 1101213310 CMS
E.R. Squibb & Sons, L.L.C. $20.02 08/27/2024 Food and Beverage Undisputed 01/23/2026 1101213336 CMS
E.R. Squibb & Sons, L.L.C. $33.06 11/07/2024 Food and Beverage Undisputed 01/23/2026 1101213362 CMS
Lexicon Pharmaceuticals, Inc. $25.66 04/09/2024 Food and Beverage Undisputed 01/23/2026 1081720779 CMS
Merck Sharp & Dohme LLC $92.00 02/22/2024 Food and Beverage Undisputed 01/23/2026 1141913646 CMS
Merck Sharp & Dohme LLC $19.11 03/27/2024 Food and Beverage Undisputed 01/23/2026 1141596954 CMS
Merck Sharp & Dohme LLC $17.06 04/19/2024 Food and Beverage Undisputed 01/23/2026 1141596918 CMS
Merck Sharp & Dohme LLC $18.45 04/30/2024 Food and Beverage Undisputed 01/23/2026 1141913650 CMS
Merck Sharp & Dohme LLC $19.29 05/13/2024 Food and Beverage Undisputed 01/23/2026 1141913648 CMS
Merck Sharp & Dohme LLC $18.57 06/12/2024 Food and Beverage Undisputed 01/23/2026 1141836152 CMS
Merck Sharp & Dohme LLC $21.14 07/09/2024 Food and Beverage Undisputed 01/23/2026 1141836064 CMS
Merck Sharp & Dohme LLC $22.96 08/16/2024 Food and Beverage Undisputed 01/23/2026 1141596920 CMS
Merck Sharp & Dohme LLC $22.64 09/05/2024 Food and Beverage Undisputed 01/23/2026 1141596924 CMS
Merck Sharp & Dohme LLC $9.68 09/27/2024 Food and Beverage Undisputed 01/23/2026 1141596916 CMS
Merck Sharp & Dohme LLC $23.53 11/01/2024 Food and Beverage Undisputed 01/23/2026 1141836066 CMS
Merck Sharp & Dohme LLC $13.94 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141596922 CMS
Novartis Pharmaceuticals Corporation $18.61 05/10/2024 Food and Beverage Undisputed 01/23/2026 1087127782 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $20.21 02/08/2024 Food and Beverage Undisputed 01/23/2026 1080657429 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $29.60 04/11/2024 Food and Beverage Undisputed 01/23/2026 1080657537 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $28.57 05/16/2024 Food and Beverage Undisputed 01/23/2026 1080657581 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $25.58 06/18/2024 Food and Beverage Undisputed 01/23/2026 1080657623 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $5.29 07/23/2024 Food and Beverage Undisputed 01/23/2026 1080657687 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $23.09 08/22/2024 Food and Beverage Undisputed 01/23/2026 1080657735 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $31.38 09/18/2024 Food and Beverage Undisputed 01/23/2026 1080657771 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $25.21 10/14/2024 Food and Beverage Undisputed 01/23/2026 1080657805 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $17.43 11/18/2024 Food and Beverage Undisputed 01/23/2026 1080657853 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.